Drug Therapy of Postprandial Hyperglycaemia

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.1, 1999-01, pp. : 19-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease

By Gude AB J Christiansen J S

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1603-1604

Informa Healthcare

Access to resources Recommend Favorite

Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus

By Giugliano D.

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 199-210

Adis International

Access to resources Recommend Favorite

Should Postprandial Hyperglycaemia in Prediabetic and Type 2 Diabetic Patients be Treated?

By Charpentier Guillaume Riveline Jean-Pierre Dardari Dured Varroud-Vial Michel

Drugs, Vol. 66, Iss. 3, 2006-01 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite

Heterogeneous Postprandial Lipoprotein Responses in the Metabolic Syndrome, and Response to Fenofibrate Therapy

By Rosenson Robert Helenowski Irene Tangney Christine

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 439-447

Springer Publishing Company

Access to resources Recommend Favorite

Drug Therapy for Children in China

By Li Zhiping Wang Yi

Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite